Billion Sails Medicine (002019.SZ): 2'-Fucosyllactose lactose has passed the review of the National Health Commission.

Intelligent Finance and Economics APP News, Yifan Pharmaceutical (002019.SZ) announced that its wholly-owned subsidiary Hangzhou Xinfu Technology Co., Ltd. received the "Administrative License Review Conclusion Notice" (Wei Shi Tian Tong Zi [2025] No. 0030) issued by the National Health Commission of the People's Republic of China ("National Health Commission") on December 4, 2025. According to the "Food Safety Law" and the "New Variety Management Measures for Food Additives," the company's administrative license application for 2'-Fucosyl Lactose was approved by the National Health Commission after review. 2'-Fucosyl Lactose is a major oligosaccharide in breast milk, with functions such as regulating intestinal flora, promoting brain development, and enhancing immunity.